The production of paediatric pharmaceutical forms represents a unique challenge within the
pharmaceutical industry. The primary goal of these formulations is to ensure therapeutic …

In the treatment of pediatric diseases, suitable dosages and dosage forms are often not
available for an adequate therapy. The use of innovative additive manufacturing techniques …

Objectives The traditional manufacturing methods of solid oral dosage forms (SODFs) are
reported to be time-consuming, highly expensive and not tailored to the patient's needs …

The recent introduction of the first FDA approved 3D-printed drug has fuelled interest in 3D
printing technology, which is set to revolutionize healthcare. Since its initial use, this rapid …

The pharmaceutical industry is progressing swiftly, driven by innovations that have led to the
discovery of novel active pharmaceutical ingredients (APIs), along with new delivery …

Embedded three-dimensional printing (e-3DP) is an emerging method for additive
manufacturing where semi-solid materials are extruded within a solidifying liquid matrix …

3D printing of pediatric-centered drug formulations can provide suitable alternatives to
current treatment options, though further research is still warranted for successful clinical …

Pharmaceutical compounding is a core activity in the preparation of patient-specific dosage
forms. In the current study we aimed to investigate whether 3D printing could be employed …

Objectives This review aims at gleaning the currently available research reports that relate to
3D printlets for paediatric patients and especially the excipients used to produce various …

3D printing technology in medicine is gaining great attention from researchers since the FDA
approved the first 3D-printed tablet (Spritam®) on the market. This technique permits the …